Together with our sponsors, our goal is to help develop successful medical agents and to provide our patients with the optimal treatment regimen. Throughout this process we strictly adhere to the standards of Good Clinical Practice (GCP) and are mindful of the economic and socioeconomic ramifications of modern drug development.

Our large pool of patients and the fact that we typically run several clinical trials concurrently enables us to assign patients the most appropriate, corresponding study regimen. Thus we select those patients we believe to potentially benefit the most from any new study drug.